Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	208.78B +43.7%
Revenue (ttm)	21.70B +39.6%
Net Income	3.33B +141.3%
EPS	15.54 +111.9%
Shares Out	211.78M
PE Ratio	63.45
Forward PE	51.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	901,880
Average Volume	766,626
Open	1,010.00
Previous Close	1,012.35
Day's Range	969.70 - 1,010.00
52-Week Range	636.10 - 1,084.00
Beta	n/a
RSI	51.46
Earnings Date	May 15, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,401
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In fiscal year 2025, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.